Trial of Cannabidiol (CBD; GWP42003-P) for Infantile Spasms (GWPCARE7)

Summary

This trial consists of 3 parts: a pilot safety phase, a pivotal randomized controlled phase, and an open-label extension phase. The pilot phase only will be described in this record. 2 cohorts of 5 participants will be enrolled sequentially. All participants will receive GWP42003-P.

Timeline

Start

2017-04-24

Primary completion

2018-05-07

Completion

2018-05-07

Drugs

Indications